©The Author(s) 2025.
World J Gastroenterol. Sep 21, 2025; 31(35): 110241
Published online Sep 21, 2025. doi: 10.3748/wjg.v31.i35.110241
Published online Sep 21, 2025. doi: 10.3748/wjg.v31.i35.110241
Table 4 Prevention of recurrent bleeding from varices
| Baveno version (reference), year of publication | First-line therapy | Alternative therapy | Rescue therapy (failure of first-line) | Gastric varices | Special considerations |
| I[8], 1992 | Traditional NSBBs or sclerotherapy | No specific recommendation | Sclerotherapy, NSBBs, surgical shunt, and liver transplantation | Traditional NSBBs | Risk assessment debated |
| II[16], 1996 | Traditional NSBBs or EBL | Combined therapy proposed but untested | TIPS or surgical shunts | No specific recommendation | Consider transplantation for advanced cirrhosis |
| III[17], 2000 | Traditional NSBBs or EBL | EBL preferred in NSBB-intolerant patients; Combined therapy should be further investigated | TIPS or surgical shunts | No specific recommendation | Consider transplantation for advanced liver disease |
| IV[18], 2005 | Traditional NSBBs + EBL | EBL preferred in NSBB-intolerant patients | TIPS or surgical shunts for Child-Pugh A/B patients; Liver transplantation for Child-Pugh B/C patients | IGV1, GOV2: N-butyl-cyanoacrylate, TIPS or NSBBs; GOV1: N-butyl-cyanoacrylate, EBL, NSBBs | Start prophylaxis by day 6 |
| V[19], 2010 | Traditional NSBBs + EBL | EBL preferred in NSBB-intolerant patients; The addition of ISMN to NSBBs for hemodynamic non-responders; Those who are unable or unwilling to be treated with EBL: NSBBs + ISMN | TIPS preferred; Surgical shunt in Child-Pugh A and B pts if TIPS is unavailable; Transplantation should be considered | IGV1, GOV2: N-butyl-cyanoacrylate or TIPS; GOV1: N-butyl-cyanoacrylate, EBL, NSBBs | TIPS as bridge to transplantation |
| VI[20], 2015 | Traditional NSBBs + EBL | NSBB monotherapy if EBL contraindicated; EBL monotherapy only if intolerance/contraindications to NSBB | TIPS preferred | No specific recommendation | PHG has to be distinguished from GAVE because treatments are different |
| VII[1], 2022 | Traditional NSBBs (including carvedilol) + EBL | Any therapy alone if intolerance the combination therapy | TIPS preferred | No specific recommendation | Argon plasma coagulation or hemospray were introduced for recurrent bleeding in PHG |
- Citation: Brzdęk M, Dobrowolska K, Janczura J, Wajdowicz M, Brzdęk K, Zarębska-Michaluk D, Gąsiorowska A, Mangia A. Advances in portal hypertension management: Evolution of the Baveno guidelines. World J Gastroenterol 2025; 31(35): 110241
- URL: https://www.wjgnet.com/1007-9327/full/v31/i35/110241.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i35.110241